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1. Introduction 
In non-ruminant mammals pyruvate derived from 
carbohydrate, and fatty acids derived from fat, are 
converted to acetyl-CoA by intramitochondrial en- 
zyme systems. The de novo synthesis of fatty acids 
is catalyzed by an extramitochondrial enzyme sys- 
tem. The transfer of the acetyl group of intramito- 
chondrial acetyl-CoA into the extramitochondrial 
space is thus an obligatory step in the de novo syn- 
thesis of fatty acids. The transfer of the acetyl group 
of intramitochondrial acetyl-CoA into the extramito- 
chondrial space occurs in the form of citrate [l-3] . 
The reactions involved in the transfer of the acetyl 
group are as follows (where I.M. and E.M. refer to 
intra- and extra-mitochondrial, respectively): 
I.M. acetyl CoA t oxaloacetate + Hz0 + citrate 
+ CoA (I) 
citrateIy. + citrateE.& (2) 
E.M. citrate + ATP t CoA + acetyl CoA + oxalo- 
acetate t ADP + Pi (3) 
E.M. oxaloacetate + DPNH + H+ + malate t DPN+ 
(4) 
malate E.M. -+ malatel.lll, (5) 
I.M. malate + DPN+ + oxaloacetate + DPNH + H+ 
(6) 
Carbon balance: acetyll.hl. -+ acetylgM. 
Hydrogen balance : 2H,.,. + 2H,.,. 
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(7) 
(8) 
The equations take into account the observation 
that rat liver mitochondria are, for physiological pur- 
poses, impermeable to oxaloacetate [4] . The carbon 
skeleton of oxaloacetate generated in reaction 3 must 
be returned to the intramitochondrial space, other- 
wise the mitochondria would become drained of di- 
carboxylates while the cytoplasm would become filled 
with them. Oxaloacetate can be converted either to 
malate or to aspartate, either of which can penetrate 
the inner mitochondrial membrane via specific carrier 
mechanisms [4]. Equations 1-8 show that the ex- 
port of one acetyl group from the mitochondria in 
the form of citrate can be associated with the entry 
of one pair of hydrogens into the mitochondria in the 
form of malate. We wish to present evidence that a 
citrate-malate shuttle operates in rat liver, and that 
this shuttle may, under some conditions, account for 
the oxidation of approximately one-half of the extra- 
mitochondrial DPNH generated during aerobic gly- 
colysis . 
2. Materials and methods 
[ 1 -14C] ethanol was obtained from New England 
Nuclear Corporation, Boston. The dietary regimen 
and the perfusion method were as described previous- 
1Y [51. 
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3. Results and discussion Table 2 
[P-Hydroxybutyrate] /[Acetoacetate] ratios in liver perfusate. 
(-)-Hydroxycitrate is a powerful inhibitor of ci- 
trate cleavage enzyme (ATP: citrate lyase) in vitro [6] , 
and an inhibitor of fatty acid synthesis in vivo [2]. 
(-)-Hydroxycitrate is believed to exert its effect on 
fatty acid synthesis by inhibiting citrate cleavage en- 
zyme (reaction 3). If this interpretation is correct, 
then fatty acid synthesis from acetate and ethanol 
should not be inhibited by (-)-hydroxycitrate, since 
acetate and ethanol can give rise to extra-mitochon- 
drial acetyl-CoA without involving the citrate cleavage 
reaction. No hydroxycitrate inhibition of acetate or 
ethanol incorporation was observed. Indeed we found 
that while hydroxycitrate inhibits fatty acid synthesis 
from carbohydrate, it actually enhances fatty acid 
synthesis from acetate or ethanol (Brunengraber and 
Lowenstein, to be published). 
Additions [@Hydroxybutyrate] / 
[acetoacetate] in perfusate 
during test period 
None 
Acetate 
Acetate and hydroxycitrate 
Ethanol 
Ethanol and hydroxycitrate 
0.82 f 0.16 
0.55 + 0.09 
0.62 f. 0.05 
0.80 f 0.15 
0.76 f. 0.19 
Conditions were as described in table 1. 
We have measured the [lactate] / [pyruvate] ratio 
(L/P) and the [P-hydroxybutyrate] / [acetoacetate] 
ratio (hereafter the B/A ratio) in the perfusates of 
livers perfused with acetate or ethanol, in the presence 
and absence of (-)-hydroxycitrate (tables 1 and 2). 
Table 1 
[Lactate] /[Pyruvate] ratios in liver perfusate. 
Additions [factate]/(pyruvate] in 
perfusate during test period 
Addition of acetate to the perfusate does not affect 
the L/P ratio. Addition of ethanol causes the well 
known increase [7--l l] in the L/P ratio from about 
8 in the controls to about 26 in the presence of ethanol 
(table 1). An interesting point is that hydroxycitrate 
causes a further increase in the L/P ratio. The effect 
is slight in the presence of acetate, the L/P ratio being 
increased from about 8- 10 5. However, the increase 
is large in the presence of ethanol, the L/P ratio being 
increased from 8 to about 100. 
Table 2 shows the p-hydroxybutyrate]/[aceto- 
acetate] ratio (B/A ratio) under various conditions. 
It is not significantly affected by the addition of acetate 
or ethanol, in the presence or absence of (-)-hydroxy- 
citrate. 
None 
Acetate 
Acetate and hydroxycitrate 
Ethanol 
Ethanol and hydroxycitrate 
8.05 f 0.25 
7.50 * 0.42 
10.5 + 0.62 
26.2 + 5.0 
98 * 13 
The livers were obtained from rats which had been schedule 
fed a diet high in glucose that lacked fat. The diet and perfu- 
sion conditions were identical to those described in ref. [ 11. 
All perfusates contained 25 mM glucose. No amino acids were 
added to the perfusate. Where indicated acetate or ethanol 
was added to the reservoir 58 min after starting the perfusion, 
to yield an initial perfusate concentration of 10 or 7 mM re- 
spectively. Where indicated (-)-hydroxycitrate was added to 
the reservoir 58 min after starting the perfusion to yield a 
final concentration of 2 mM. Samples of perfusate were with- 
drawn for analysis of lactate and pyruvate at 15, 30,45, and 
57 min (control period), and at 75,90,105, and 120 min 
(test period). The control group consisted of 29 perfusions; 
the test groups each consisted of 6 perfusions. The [lactate] /
[pyruvate] ratio during the control period was 7.05 f 0.15 
(SE.). [Lactate] plus [pyruvate] production during the con- 
trol period was 4.43 f 0.20 mM. 
Our interpretation of these results is as follows. The 
reducing equivalents generated in the cytoplasm during 
glycolysis are transferred to the mitochondria in part 
through a citrate-malate shuttle (reactions l-6). In 
this shuttle, citrate leaves the mitochondria and is 
cleaved to acetyl-CoA and oxaloacetate in the cyto- 
plasm via the citrate cleavage reaction. The acetyl- 
CoA is used for fatty acid synthesis. The oxaloacetate 
made in the same reaction serves to oxidize one mole- 
cule of DPNH via the cytoplasmic malate dehydrogen- 
ase reaction, and then malate passes back into the 
mitochondria. It can be calculated that under condi- 
tions when the rate of fatty acid synthesis is high [5 1, 
that the citrate-malate shuttle can oxidize at least 45% 
of the extra-mitochondrial DPNH generated during 
glycolysis. Addition of ethanol puts a new burden on 
the shuttles responsible for the oxidation of cyto- 
plasmic DPNH, and leads to a higher L/P ratio. Addi- 
tion of hydroxycitrate on top of the ethanol inhibits 
not only fatty acid synthesis, but also the generation 
131 
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of oxaloacetate from citrate. In other words, one of 
the major hydrogen shuttles becomes strongly in- 
hibited and this results in a large increase in the L/P 
ratio. The observation that the B/A ratio remains un- 
affected indicates that the rate limiting step(s) occur(s) 
before the formation of intramitochondrial DPNH. 
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